He underwent BAV ([**2133-9-23**]) with some improvement and was referred for further aortic valve treatment options.
He enrolled in the Corevalve TAVI study and was excluded due to large annular size.
Neuro: Flat affect, unsteady gait, slight shuffling, gross FROM Pulses: palpable distal pulses   Pertinent Results: [**Hospital1 18**] ECHOCARDIOGRAPHY REPORT  [**Known lastname 91437**], [**Known firstname **]       [**Hospital1 18**] [**Numeric Identifier 91438**] (Congenital) Done [**2134-3-17**] at 11:11:41 AM      FINAL Referring Physician     [**Name9 (PRE) **] Information [**Name9 (PRE) **], [**First Name3 (LF) 177**] C. [**Hospital Unit Name 927**] [**Location (un) 86**], [**Numeric Identifier 718**]  Status: Inpatient DOB: [**2047-3-10**] Age (years): 87 M  Hgt (in): 67 BP (mm Hg): 132/61  Wgt (lb): 172 HR (bpm): 60  BSA (m2): 1.90 m2 Indication: Aortic valve disease.
Preoperative assessment.
ICD-9 Codes: 424.1, 424.0, 746.9 Test Information Date/Time: [**2134-3-17**] at 11:11    Interpret MD: [**First Name8 (NamePattern2) **] [**Name8 (MD) 17792**], MD Test Type: TEE (Congenital) Son[**Name (NI) 930**]: [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **], MD Doppler: Full Doppler and color Doppler Test Location: Anesthesia West OR cardiac Contrast: None Tech Quality: Adequate Tape #: 2012AW-1: Machine: p2 Echocardiographic Measurements Results  Measurements  Normal Range Left Atrium - Long Axis Dimension:  *5.0 cm  <= 4.0 cm Left Atrium - Four Chamber Length:  *6.2 cm  <= 5.2 cm Left Ventricle - Septal Wall Thickness:  *1.3 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  *1.3 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  3.8 cm  <= 5.6 cm Left Ventricle - Ejection Fraction:  50% to 55%  >= 55% Left Ventricle - Stroke Volume:  52 ml/beat Left Ventricle - Cardiac Output:  3.12 L/min Left Ventricle - Cardiac Index:  *1.64  >= 2.0 L/min/M2 Left Ventricle - Lateral Peak E':  0.10 m/s  > 0.08 m/s Left Ventricle - Septal Peak E':  *0.08 m/s  > 0.08 m/s Left Ventricle - Ratio E/E':  8  < 15 Aorta - Annulus:  3.0 cm  <= 3.0 cm Aorta - Sinus Level:  3.6 cm  <= 3.6 cm Aorta - Sinotubular Ridge:  2.8 cm  <= 3.0 cm Aorta - Ascending:  *3.6 cm  <= 3.4 cm Aorta - Arch:  2.9 cm  <= 3.0 cm Aorta - Descending Thoracic:  2.4 cm  <= 2.5 cm Aortic Valve - Peak Velocity:  *3.6 m/sec  <= 2.0 m/sec Aortic Valve - Peak Gradient:  *52 mm Hg  < 20 mm Hg Aortic Valve - Mean Gradient:  31 mm Hg Aortic Valve - LVOT pk vel:  0.60 m/sec Aortic Valve - LVOT VTI:  15 Aortic Valve - LVOT diam:  2.1 cm Aortic Valve - Valve Area:  *0.7 cm2  >= 3.0 cm2 Mitral Valve - E Wave:  0.7 m/sec Mitral Valve - A Wave:  0.6 m/sec Mitral Valve - E/A ratio:  1.17  Findings LEFT ATRIUM: Marked LA enlargement.
See Conclusions for post-bypass data Conclusions PRE-BYPASS: No spontaneous echo contrast is seen in the body of the left atrium or left atrial appendage.
Overall left ventricular systolic function is low normal (LVEF 50-55%).
There is a mean gradient of 11 mmHg at a cardiac output of 3.7 L/min.
Electronically signed by [**First Name8 (NamePattern2) **] [**Name8 (MD) 17792**], MD, Interpreting physician [**Last Name (NamePattern4) **] [**2134-3-17**] 16:45  [**2134-3-20**] 04:15AM BLOOD WBC-8.0 RBC-3.12* Hgb-9.9* Hct-28.6* MCV-92 MCH-31.7 MCHC-34.6 RDW-14.7 Plt Ct-103* [**2134-3-20**] 04:15AM BLOOD Glucose-89 UreaN-34* Creat-1.5* Na-141 K-3.8 Cl-104 HCO3-30 AnGap-11  Brief Hospital Course: Mr. [**Known lastname **] is an 87 year old male with a complex past medical history including balloon aortic valvuloplasty in [**2133-9-14**], coronary artery bypass grafting times three in [**2127**] who presented with worsening dyspnea on exertion, fatigue and a presyncopal episode.
Medications on Admission: Active Medication list as of [**2134-3-7**]:  Medications - Prescription ALLOPURINOL -  (Prescribed by Other Provider) - 100 mg Tablet - 1 Tablet(s) by mouth once a day ATENOLOL -  (Prescribed by Other Provider) - 25 mg Tablet - 1 Tablet(s) by mouth twice a day CARBIDOPA-LEVODOPA-ENTACAPONE [STALEVO 150] -  (Prescribed by Other Provider) - 37.5 mg-150 mg-200 mg Tablet - 1 Tablet(s) by mouth four times a day CLINDAMYCIN HCL -  (Prescribed by Other Provider) - 150 mg Capsule - 4 Capsule(s) by mouth 1 hr prior to dental ESCITALOPRAM [LEXAPRO] -  (Prescribed by Other Provider) - 5 mg Tablet - 0.5 (One half) Tablet(s) by mouth once a day GLIPIZIDE -  (Prescribed by Other Provider) - 5 mg Tablet - 1 Tablet(s) by mouth 2x/day OLOPATADINE [PATADAY] -  (Prescribed by Other Provider) - 0.2 % Drops - 1 gtt in each eye  as needed for prn RIVASTIGMINE [EXELON] -  (Prescribed by Other Provider) - 4.6 mg/24 hour Patch 24 hr - 1 patch once a day SIMVASTATIN -  (Prescribed by Other Provider) - 10 mg Tablet - 1 Tablet(s) by mouth once a day TAMSULOSIN [FLOMAX] -  (Prescribed by Other Provider) - 0.4 mg Capsule, Ext Release 24 hr - 1 Capsule(s) by mouth once a day  Medications - OTC ASPIRIN -  (Prescribed by Other Provider) - 81 mg Tablet, Delayed Release (E.C.)
)(s)* Refills:*2* 2. simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Capsule, Ext Release 24 hr(s)* Refills:*2* 5. rivastigmine 4.6 mg/24 hour Patch 24 hr Sig: One (1) Transdermal daily ().
